Eton Pharmaceuticals (ETON) Free Cash Flow (2018 - 2025)
Eton Pharmaceuticals (ETON) posted Free Cash Flow of -$11.6 million for Q4 2025, down 198.79% sequentially from $11.7 million in Q3 2025, and down 1392.92% YoY from $897192.9 in Q4 2024.
Eton Pharmaceuticals (ETON) Free Cash Flow (2018 - 2025) Analysis & Trends
Eton Pharmaceuticals has reported Free Cash Flow for 8 years, with the latest figure at -$11.6 million in Q4 2025.
- Quarterly Free Cash Flow fell 1392.92% year-over-year to -$11.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.2 million (up 980.7% YoY) and the FY2025 annual result came in at $10.2 million, up 980.7% from the prior year.
- Free Cash Flow retreated to -$11.6 million in Q4 2025 per ETON's latest filing, from $11.7 million in the prior quarter.
- Over five years, Free Cash Flow peaked at $11.7 million in Q3 2025 and troughed at -$11.6 million in Q4 2025.
- A 5-year average of $900250.0 and a median of $1.0 million in 2022 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2022 and 2025: Free Cash Flow jumped 763.96% in 2022, then sank 1392.92% in 2025.
- Over 5 years, Free Cash Flow stood at -$5.1 million in 2021, then soared by 155.22% to $2.8 million in 2022, then plunged by 86.32% to $387000.0 in 2023, then sank by 300.78% to -$777000.0 in 2024, then tumbled by 1392.92% to -$11.6 million in 2025.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$11.6 million, $11.7 million, and $8.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Eton Pharmaceuticals | 1.65 Bn | 1.62 Bn | 25.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -11.60 Mn |
| Dec 31, 2025 | -11.60 Mn |
| Sep 30, 2025 | 11.74 Mn |
| Sep 30, 2025 | 11.74 Mn |
| Jun 30, 2025 | 7.96 Mn |
| Jun 30, 2025 | 7.96 Mn |
| Mar 31, 2025 | 2.09 Mn |
| Mar 31, 2025 | 2.09 Mn |
| Dec 31, 2024 | -777,000.00 |
| Dec 31, 2024 | -777,000.00 |
| Sep 30, 2024 | 2.95 Mn |
| Sep 30, 2024 | 2.95 Mn |
| Jun 30, 2024 | 1.26 Mn |
| Jun 30, 2024 | 1.26 Mn |
| Mar 31, 2024 | -2.49 Mn |
| Mar 31, 2024 | -2.49 Mn |
| Dec 31, 2023 | 387,000.00 |
| Dec 31, 2023 | 387,000.00 |
| Sep 30, 2023 | 873,000.00 |
| Sep 30, 2023 | 873,000.00 |